2017
DOI: 10.15171/ps.2017.07
|View full text |Cite
|
Sign up to set email alerts
|

A Colon Targeted Delivery System for Resveratrol Enriching in pH Responsive-Model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 38 publications
0
4
0
Order By: Relevance
“…The antioxidant activity of the samples was determined by the DPPH method according to recent study (Peršurić et al, 2020 ) with some modifications. An alcoholic DPPH solution is reduced the existence of a hydrogen‐donating antioxidant (Andishmand et al, 2016 ; Soltanzadeh et al, 2022 ). DPPH reagent was obtained by dissolving 4‐mg DPPH in 100‐mL ethanol 96%.…”
Section: Methodsmentioning
confidence: 99%
“…The antioxidant activity of the samples was determined by the DPPH method according to recent study (Peršurić et al, 2020 ) with some modifications. An alcoholic DPPH solution is reduced the existence of a hydrogen‐donating antioxidant (Andishmand et al, 2016 ; Soltanzadeh et al, 2022 ). DPPH reagent was obtained by dissolving 4‐mg DPPH in 100‐mL ethanol 96%.…”
Section: Methodsmentioning
confidence: 99%
“…The stability, bioactivity, and bioavailability of active substances are essential to develop fortified foods (Andishmand et al, 2016). Food fortification is challenging because of the incompatibility of the fortifier with the food matrix, storage stability, and the possibility of changes in sensory characteristics (Faccinetto-Beltrán et al, 2021).…”
Section: Nanoe N C a Psu L At Ion Of Ac Tive Subs Tan Ce Smentioning
confidence: 99%
“…However, for a range of therapeutics, food supplements and probiotics delivery to the colon is important. This is especially true for a range of inflammatory diseases of the GI-tract such as Crohn’s disease and Ulcerative colitis [ 1 , 2 , 3 , 4 , 5 , 6 ] but also for other diseases in the colon that would benefit from a local treatment including colon cancer [ 7 , 8 ], enteric nematodes [ 9 ] and enzyme replacement therapies [ 10 ]. Other areas of interest are colon delivery of proteins and peptides [ 11 , 12 ], probiotic bacteria [ 13 , 14 ] and microbiota replacement therapies [ 15 ].…”
Section: Introductionmentioning
confidence: 99%